The Circles Platform requires no third-party data to generate high quality, fit-for-purpose real-world evidence for any clinical, regulatory or commercial healthcare goal. The patented closed system can ensure unambiguous ownership for Circles Datasets licensees.
Real-time quality and safety metrics. Constantly updated evidence bases for centers of excellence. TEAM, CJR-X and other bundled care, pre-admission and post-discharge. Prior authorization defensible documentation. Continual physician and patient engagement/education. Monetization of everyday real-world data. Research, publication. SDOH. Legal/regulatory. TEMPO (FDA) and ACCESS (CMS).
Hospitals solutionsHigher quality, real-time, outcomes-based datasets. Prior authorization defensible documentation. Narrow networks. Health plan member segmentation. Outcomes beyond the payment window, by diagnosis, treatment, product and provider group. Support for the ACCESS Payer Pledge. Member engagement through their own recovery data.
Payer solutionsPost-market surveillance: FDA Section 522 studies and EU post-market clinical follow-up. Regulatory submissions and label expansion. Coverage evidence: CED, TCET and EU joint clinical assessment. External controls and rare-disease natural history. Long-term GLP-1 outcomes and safety. Competitive intelligence. TEMPO (FDA) and ACCESS (CMS).
Life sciences solutionsNew funding sources. Stronger impact, delivery on mission statement. Competitive differentiation. Deeper, continual value for members.
Society solutionsRural Health Transformation Program. National opioid abatement programs. CMS Medicaid Quality Pledge. Measurable results across many small providers.
Government & MSO solutionsIndependent reference datasets with outcomes a model was never trained on. Domain-specific expert clinical panels for validation.
AI solutions